Casadio Tarabusi C, Vickery G
Publications Service, OECD, Paris, France.
Int J Health Serv. 1998;28(2):281-303. doi: 10.2190/B6VR-NND7-46BL-PY5G.
This is the second of a two-part report on the pharmaceutical industry. Part II begins with a discussion of foreign direct investment and inter-firm networks, which covers international mergers, acquisitions, and minority participation; market shares of foreign-controlled firms; international collaboration agreements (with a special note on agreements in biotechnology); and licensing agreements. The final section of the report covers governmental policies on health and safety regulation, price regulation, industry and technology, trade, foreign investment, protection of intellectual property, and competition.
这是一份关于制药行业的两份报告中的第二部分。第二部分首先讨论外国直接投资和企业间网络，内容包括国际并购、少数股权参与；外资控股公司的市场份额；国际合作协议（特别提及生物技术领域的协议）；以及许可协议。报告的最后一部分涵盖政府在健康与安全监管、价格监管、产业与技术、贸易、外国投资、知识产权保护以及竞争方面的政策。
